Dale White was in prison for only seven months, but it was long enough for him to figure out that he needed to make some changes in his life. The third man in a two-man cell, White slept on the floor, next to the toilet, in what inmates call a foam.
Don t miss the big stories. Like us on Facebook.
MONTPELIER â The Vermont court system plans to use nearly $13.6 million in federal money to ease a significant backlog of cases caused by the COVID-19 pandemic.
Court Administrator Patricia Gabel said eliminating the backlog of cases, particularly jury trials, requires an investment in personnel and technology.
She presented the plan on Wednesday to the Vermont Senate Judiciary Committee.
Select courthouses have been identified to start holding trials in May. Gabel s plan calls for using the money from the American Rescue Plan Act over three-and-a-half-years.
Aside from jury trials, the courts have managed to handle casework through the pandemic, but there is a sense that when things open up the workload in the courts will increase, The Caledonian Record reported.
Vermont delaying J&J vaccines through April 23 over clot worries
The newly available Johnson & Johnson COVID-19 vaccine sits in a refrigerator at South Shore University Hospital on March 03, 2021, in Bay Shore, New York. (Spencer Platt/Getty Images/TNS)
Modified: 4/15/2021 8:12:58 PM
Related stories
MONTPELIER The Vermont Health Department is extending for another week a pause on the use of the Johnson & Johnson vaccine against COVID-19, officials said Thursday.
State officials say the pause through April 23 is in line with the advice of the U.S. Centers for Disease Control and Prevention.
Scientists say they need more time to study the Johnson & Johnson vaccine after six cases of a rare blood clot were reported in the U.S. among the more than 7.2 million people who had received that vaccine.
Vermont delaying J&J vaccines another week over clot worries
April 15, 2021 GMT
MONTPELIER, Vt. (AP) The Vermont Health Department is extending for another week a pause on the use of the Johnson & Johnson vaccine against COVID-19, officials said Thursday.
State officials say the pause through April 23 is in line with the advice of the U.S. Centers for Disease Control and Prevention.
Scientists say they need more time to study the Johnson & Johnson vaccine after six cases of a rare blood clot were reported in the U.S. among the more than 7.2 million individuals who had received that vaccine.
In Vermont, appointments for all two-dose vaccines, from Pfizer and Moderna, will continue as scheduled.
Don t miss the big stories. Like us on Facebook.
MONTPELIER, Vt. (AP) â The Vermont Health Department is extending for another week a pause on the use of the Johnson & Johnson vaccine against COVID-19, officials said Thursday.
State officials say the pause through April 23 is in line with the advice of the U.S. Centers for Disease Control and Prevention.
Scientists say they need more time to study the Johnson & Johnson vaccine after six cases of a rare blood clot were reported in the U.S. among the more than 7.2 million individuals who had received that vaccine.
In Vermont, appointments for all two-dose vaccines, from Pfizer and Moderna, will continue as scheduled.